Warren Buffett’s company just dumped $800 million worth of Apple stock… and moved it into biotech.
Biotech is easily the biggest industry of the year… and the timing is perfect for three biotech stocks that just popped up on my radar.
The first one’s recent Phase II trials are one of the most exciting developments in the industry. It’s inching closer to FDA approval.
The second generated $339 million off a new product last year… and it has another one in the pipeline. Once approved, it could help the company generate $2.5 billion by 2024…
And the third could not only be the #1 biotech stock of 2020...
But it could be the #1 Stock of this Generation. Jeff Bezos, Peter Thiel, and the Rockefellers are betting a colossal nine figures on it.
Sign up below for our 3-stock report and receive ongoing updates from Stock Market Junkie.
By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. We will never share your email address, and you can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works
